Herbas VPB

Print
EN | LT
LT - Piperidinilindolo dariniai ir jų panaudojimas kaip komplemento faktoriaus B inhibitorių
EN - PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/14 (2006.01)
C07D 413/14 (2006.01)
C07D 401/06 (2006.01)
C07D 403/06 (2006.01)
C07D 417/14 (2006.01)
A61K 31/454 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/5377 (2006.01)
A61P 27/00 (2006.01)
A61P 37/00 (2006.01)
European patent
(11) Number of the document 3022192
(13) Kind of document T
(96) European patent application number 14744744.5
Date of filing the European patent application 2014-07-14
(97) Date of publication of the European application 2016-05-25
(45) Date of publication and mention of the grant of the patent 2017-10-11
(46) Date of publication of the claims translation 2017-12-14
PCT application
(86) Number PCT/US2014/046515
Date 2014-07-14
PCT application publication
(87) Number WO 2015/009616
Date 2015-01-22
Priority applications
(30) Number Date Country code
201361846355 P 2013-07-15 US
201461977028 P 2014-04-08 US
Inventors
(72)
ADAMS, Christopher, US
CAPPARELLI, Michael Paul, US
EHARA, Takeru, US
KARKI, Rajeshri Ganesh, US
MAINOLFI, Nello, US
ZHANG, Chun, US
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Piperidinilindolo dariniai ir jų panaudojimas kaip komplemento faktoriaus B inhibitorių
  PIPERIDINYL INDOLE DERIVATIVES AND THEIR USE AS COMPLEMENT FACTOR B INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2025-06-18 12 289.00 EUR
Next renewal fee
2026-07-14